Pranidipine, a 1,4-dihydropyridine calcium channel blocker that enhances nitric oxide-induced vascular relaxation

Cardiovascular Drug Reviews

Volumn 19, Issue 1, 2001, Pages 1-8

  Mori, Toyoki ^a   Takase, Hiromichi ^a   Toide, Kiyotaka ^a   Hirano, Takahiro ^a   Kambe, Toshimi ^a   Nakayama, Natsuki ^a   Schwartz, Arnold ^b  

^a OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

1,4 Dihydropyridines; Antianginal drugs; Antihypertensive drugs; Calcium channel blockers; Cyclic GMP; NO; Peripheral edema; Pranidipine; Target organ protection; Venodilation

Indexed keywords

1,4 DIHYDROPYRIDINE; ACETYLCHOLINE; AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; CYCLIC GMP; NIFEDIPINE; NITRIC OXIDE; PRANIDIPINE;

ANGINA PECTORIS; CAROTID ARTERY; CLINICAL TRIAL; DRUG ACTIVITY; DRUG INHIBITION; DRUG MECHANISM; EDEMA; ENDOTHELIUM; GENE EXPRESSION; HUMAN; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; VASODILATATION;

EID: 0035074114     PISSN: 08975957     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3466.2001.tb00179.x     Document Type: Review

References (36)

1. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle
2. Dihydropyridine calcium antagonist-induced modulation of endotherial function: A Review
3. Amlodipine: A new calcium antagonist
4. Dual mode of action of dihydropyridine calcium antagonists: A role for nitric oxide
5. Action of 1,4-dihydropyridines in isolated mesenteric vascular beds
6. Calcium channel blockade enhances nitric oxide synthase expression by cultured endothelial cells
7. Calcium antagonism and calcium entry blockade
8. Nitric oxide (EDRF) enhances the vasorelaxing effect of nitrendipine in various isolated arteries
9. Differential properties of the optical-isomers of pranidipine, a 1,4-dihydropyridine calcium channel modulator
10. Venodilator effects of pranidipine, a novel 1,4-dihydropyridine calcium antagonist, in rats: Comparison with nifedipine and amlodipine
11. Clinical evaluation of pranidipine (OPC-13340) in patients with angina pectoris. Double-blind comparison study with slow-release nifedipine
12. Effects of pranidipine, a calcium channel antagonist, in an avian model of heart failure
13. Nifedipine-induced coronary vasodilation in ischemic hearts is attributable to bradykinin- and NO-dependent mechanisms in dogs
14. A Ca channel blocker, benidipine, increases coronary blood flow and attenuates the severity of myocardial ischemia via NO-dependent mechanisms in dogs
15. Pranidipine enhances relaxation produced by endothelium-derived relaxing factor in carotid artery
16. Mechanisms of the potent long-lasting antihypertensive action of the new calcium channel blocker pranidipine. Evidence for strong affinity to the calcium channels or membrane
17. Cardiovascular effects of OPC-13340, a potent, long-acting 1,4-dihydropyridine calcium channel blocker, in dogs
18. Pranidipine, a new 1,4-dihydropyridine calcium channel blocker, enhances cyclic GMP-independent nitric oxide-induced relaxation of the rat aorta
19. Characterization of the renal action of pranidipine in the rat
20. OPC-13340, a new potent long-acting dihydropyridine calcium antagonist
21. Antihypertensive activity of OPC-13340, a new potent and long-acting dihydropyridine calcium antagonist, in rats
22. Effects of the new long-acting dihydropyridine calcium antagonist pranidipine on the endothelium-dependent relaxation in isolated rat aorta in vitro
23. Hemodynamic effects of the calcium channel blocker pranidipine on exercise-induced angina
24. Effects of pranidipine in the animal model of angina
25. Effects of pranidipine (OPC-13340), a novel 1,4-dihydropyridine derivative Ca-antagonist, on isolated porcine coronary contraction and acute myocardial ischemia in the pig
26. The effect of the calcium-antagonist nitrendipine on intracellular calcium concentration in endothelial cells
27. 19F-NMR spectroscopy
28. 19F-NMR spectroscopy
29. Differences in cardiovascular profile among calcium antagonists
30. Long-acting calcium channel antagonist pranidipine prevents ventricular remodeling after myocardial infarction in rats
31. New dihydropyridine calcium channel antagonist, pranidipine, attenuates hypertensive renal injury in Dahl salt-sensitive rats
32. In vivo receptor occupancy and plasma concentration of pranidipine, a potent and long-acting dihydropyridine calcium antagonist
33. Pranidipine enhances the action of nitric oxide released from endothelial cells
34. Amlodipine releases nitric oxide from canine coronary microvessels: An unexpected mechanism of action of a calcium channel-blocking agent
35. Amlodipine enhances NO production induced by an ACE inhibitor through a kinin-mediated mechanism in canine coronary microvessels